Related Experiment Video

Updated: May 25, 2026

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

[Molecular pathogenesis of hereditary motor and sensory neuropathy]

Katarzyna Kotruchow1, Dagmara Kabzińska, Kamila Karpińska

  • 1Zespół chorób nerwowo-mieśniowych Instytutu Medycyny Doświadczalnej i Klinicznej im. M. Mossakowskiego Polskiej Akademii Nauk, Warszawa. k.kotruchow@gmail.com

Postepy Biochemii
|January 13, 2012
PubMed

Insights

Charcot-Marie-Tooth disease type 2 (CMT2) is a diverse inherited neuropathy. This review explores CMT2

Area of Science:

  • Neurology
  • Genetics
  • Molecular Biology

Context:

  • Charcot-Marie-Tooth disease type 2 (CMT2) is a heterogeneous inherited axonal neuropathy.
  • Fifteen subtypes, 14 loci, and 13 genes are currently identified as causative of CMT2.
  • Understanding the molecular pathogenesis is crucial for developing effective therapies.

Purpose:

  • To review current knowledge of Charcot-Marie-Tooth disease type 2.
  • To discuss the diverse pathogenetic mechanisms underlying CMT2.
  • To highlight the challenges in CMT2 research due to protein diversity.

Summary:

  • CMT2 involves inherited axonal motor and sensory neuropathy with significant clinical and genetic heterogeneity.
  • Pathogenesis involves diverse proteins, including mitochondrial outer membrane proteins (mitofusin 2, GDAP1) regulating mitochondrial dynamics, tRNA-synthetases, cytoskeletal proteins, ion channels, and chaperones.
  • The review consolidates information on CMT2 and its complex molecular mechanisms.

Impact:

  • Provides a comprehensive overview of CMT2, aiding researchers in understanding disease mechanisms.
  • Identifies key proteins and pathways involved in CMT2 pathogenesis.
  • Facilitates the search for targeted therapeutic strategies for CMT2 patients.

More Related Videos

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration06:35

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration

Published on: June 15, 2018

Dissection of the Transversus Abdominis Muscle for Whole-mount Neuromuscular Junction Analysis06:12

Dissection of the Transversus Abdominis Muscle for Whole-mount Neuromuscular Junction Analysis

Published on: January 11, 2014

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...